Literature DB >> 20716659

LupusQoL-US benchmarks for US patients with systemic lupus erythematosus.

Meenakshi Jolly1, Simon A Pickard, Rachel A Mikolaitis, Roger A Rodby, Winston Sequeira, Joel A Block.   

Abstract

OBJECTIVE: The LupusQoL-US instrument was recently validated in the US. We studied the benchmarks for a US patient cohort with systemic lupus erythematosus (SLE) and relevant demographic and disease correlates.
METHODS: LupusQoL-US was administered to 185 patients with SLE. Demographic data (age, sex, ethnicity, marital status) and disease features (duration, disease activity and damage) were assessed simultaneously. Descriptive statistics were obtained. LupusQoL-US domain scores were calculated, and compared by sex, ethnicity, and marital status using nonparametric tests. Correlation between LupusQoL-US domains and age, disease duration, disease activity, and disease damage were obtained.
RESULTS: Mean age of patients was 42.2 +/- 14.5 years; 94% of subjects were women. African American patients comprised 60% of the study cohort. The most affected domains were Fatigue and Physical Health. The least affected was Intimate Relationships. Age correlated with Physical Health, Pain, and Body Image (r = 0.15-0.18). Differences were observed based on sex and marital status, but not by ethnicity; there the LupusQoL-US correlated inversely with disease activity (r = -0.001 to -0.36) and damage (r = -0.003 to -0.40).
CONCLUSION: All domains of the LupusQoL-US based health related quality of life (HRQOL) were affected adversely. HRQOL varied by age, sex, and marital status in our SLE cohort.

Entities:  

Mesh:

Year:  2010        PMID: 20716659     DOI: 10.3899/jrheum.091443

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

Review 1.  Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus.

Authors:  Anisha B Dua; Zahi Touma; Sergio Toloza; Meenakshi Jolly
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

2.  Quality of life in patients with systemic lupus erythematosus (SLE) compared with related controls within a unique African American population.

Authors:  A Barnado; L Wheless; A K Meyer; G S Gilkeson; D L Kamen
Journal:  Lupus       Date:  2011-10-26       Impact factor: 2.911

Review 3.  The humanistic and economic burden of systemic lupus erythematosus : a systematic review.

Authors:  Rachel Meacock; Nicola Dale; Mark J Harrison
Journal:  Pharmacoeconomics       Date:  2013-01       Impact factor: 4.981

Review 4.  Patient-Reported Outcomes in Systemic Lupus Erythematosus.

Authors:  Mary Mahieu; Susan Yount; Rosalind Ramsey-Goldman
Journal:  Rheum Dis Clin North Am       Date:  2016-03-17       Impact factor: 2.670

5.  The Chinese version of the SLEQOL is a reliable assessment of health-related quality of life in Han Chinese patients with systemic lupus erythematosus.

Authors:  Hai-Zhi Jiang; Zhi-Guo Lin; Hong-Juan Li; Qing -Du; Wei -Tian; Shu-Ya Wang; Shang-Qi Guan; Yi-Fang Mei
Journal:  Clin Rheumatol       Date:  2017-11-22       Impact factor: 2.980

Review 6.  Health-related quality of life measurement in adult systemic lupus erythematosus: Lupus Quality of Life (LupusQoL), Systemic Lupus Erythematosus-Specific Quality of Life Questionnaire (SLEQOL), and Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL).

Authors:  Jinoos Yazdany
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

7.  Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the LupusQol.

Authors:  I Etchegaray-Morales; S Méndez-Martínez; C Jiménez-Hernández; C Mendoza-Pinto; N E Alonso-García; A Montiel-Jarquín; A López-Colombo; A García-Villaseñor; M H Cardiel; M García-Carrasco
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

8.  Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus.

Authors:  Alvaro Gomez; Victor Qiu; Arvid Cederlund; Alexander Borg; Julius Lindblom; Sharzad Emamikia; Yvonne Enman; Jon Lampa; Ioannis Parodis
Journal:  Front Med (Lausanne)       Date:  2021-04-16

9.  Impact of demographic, clinical, and treatment compliance characteristics on quality of life of Venezuelan patients with systemic lupus erythematosus.

Authors:  Fhabián S Carrión-Nessi; María V Marcano-Rojas; Sinibaldo R Romero Arocha; Daniela L Mendoza Millán; David A Forero-Peña; Allen W Antuarez-Magallanes; Soham Al Snih; Martín A Rodríguez; Yurilís J Fuentes-Silva
Journal:  BMC Rheumatol       Date:  2022-01-04

10.  Psychometric Analysis from EMBODY1 and 2 Clinical Trials to Help Select Suitable Fatigue PRO Scales for Future Systemic Lupus Erythematosus Studies.

Authors:  Sophie Cleanthous; Sabine Bongardt; Patrick Marquis; Christian Stach; Stefan Cano; Thomas Morel
Journal:  Rheumatol Ther       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.